The analysis in human HCC specimens suggests etiological linking gp78 loss to HCC and putative tumor suppression although the exact molecular mechanisms underlying progression of NASH to cancer are yet to be determined in gp78-KO mice. This evidence concerns the gene AMFR and metabolic dysfunction-associated steatohepatitis.